Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05874726 · ClinicalTrials.gov registry record

Biological Sample Repository for Gastrointestinal Disorders

A clinical trial of Obesity and Diabetes Mellitus, Type 2, sponsored by Pichamol Jirapinyo, MD, MPH.

Active
Registry status
500
Enrollment target
1
Study location

NCT05874726 is a study of Obesity and Diabetes Mellitus, Type 2 that is active but no longer recruiting, run by Pichamol Jirapinyo, MD, MPH. The registered enrollment target is 500 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05874726, a study of Obesity and Diabetes Mellitus, Type 2, is active but no longer recruiting, sponsored by Pichamol Jirapinyo, MD, MPH.

ACTIVE NOT RECRUITING
Registry status
500 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational study has the purpose of collecting biological samples from obese patients undergoing evaluation for weight loss by means of medical or endoscopic therapies; and of post bariatric surgery patients presenting with short- and long-term surgical complications. The aim is to enhance the overall understanding of the mechanisms leading to obesity, weight loss, failure to lose weight, and weight regain following treatment. Additional goals are to determine the efficacy of endoscopic and surgical procedures, to identify potential therapeutic targets and disease biomarkers that predict response to therapy.

Conditions Studied

Obesity Diabetes Mellitus, Type 2 Diabetes Mellitus Overweight Overweight and Obesity Overweight or Obesity Diabetes Type 2 Obesity, Morbid Gastro-Intestinal Disorder Obesity, Primary

Interventions

  • DIAGNOSTIC_TEST Blood Collection
  • DIAGNOSTIC_TEST Urine Collection
  • DIAGNOSTIC_TEST Tissue Sample Collection

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2023-07-19
Est. Completion 2029-04

Sponsor

Pichamol Jirapinyo, MD, MPH

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05874726

The ClinicalTrials.gov registry entry for NCT05874726 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (39% lower). The listed sponsor is Pichamol Jirapinyo, MD, MPH, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Blood Collection is the first listed.

NCT05874726 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05874726 about?

NCT05874726 is a clinical study titled "Biological Sample Repository for Gastrointestinal Disorders". The goal of this observational study has the purpose of collecting biological samples from obese patients undergoing evaluation for weight loss by means of medical or endoscopic therapies; and of post bariatric surgery patients presenting with short- and long-term surgical complications. The aim is ...

What is the current status of trial NCT05874726?

This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2023-07-19. Estimated completion is 2029-04.

What conditions does trial NCT05874726 study?

This clinical trial studies the following conditions: Obesity, Diabetes Mellitus, Type 2, Diabetes Mellitus, Overweight, Overweight and Obesity.

What interventions are being tested in trial NCT05874726?

The interventions under investigation include: Blood Collection (DIAGNOSTIC_TEST), Urine Collection (DIAGNOSTIC_TEST), Tissue Sample Collection (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05874726?

This trial is sponsored by Pichamol Jirapinyo, MD, MPH, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05874726 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Obesity

All registered trials for this condition

Diabetes Mellitus, Type 2

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.